Cancer drug trial halted early: what happened?
Disease control
Terminated
This early-stage study tested a new drug, DS-9606a, in 88 adults with advanced solid tumors that have a specific protein called Claudin-6. The main goal was to check safety and find the right dose. The trial was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC